Your browser doesn't support javascript.
loading
Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector function.
Popp, Oliver; Moser, Samuel; Zielonka, Jörg; Rüger, Petra; Hansen, Silke; Plöttner, Oliver.
  • Popp O; a Roche Pharma Research and Early Development , Large Molecule Research, Roche Innovation Center Munich , Nonnenwald 2, Penzberg , Germany.
  • Moser S; b Roche Pharma Research and Early Development , Large Molecule Research, Roche Innovation Center Zurich , Wagistrasse 18, Schlieren , Switzerland.
  • Zielonka J; b Roche Pharma Research and Early Development , Large Molecule Research, Roche Innovation Center Zurich , Wagistrasse 18, Schlieren , Switzerland.
  • Rüger P; a Roche Pharma Research and Early Development , Large Molecule Research, Roche Innovation Center Munich , Nonnenwald 2, Penzberg , Germany.
  • Hansen S; a Roche Pharma Research and Early Development , Large Molecule Research, Roche Innovation Center Munich , Nonnenwald 2, Penzberg , Germany.
  • Plöttner O; a Roche Pharma Research and Early Development , Large Molecule Research, Roche Innovation Center Munich , Nonnenwald 2, Penzberg , Germany.
MAbs ; 10(2): 290-303, 2018.
Article en En | MEDLINE | ID: mdl-29173063
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ingeniería Genética / Células CHO / Anticuerpos Monoclonales Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Ingeniería Genética / Células CHO / Anticuerpos Monoclonales Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article